Findings represent first evidence of ALK activity in inflammatory breast cancer. Data emphasize importance of proteins and enzymes to define molecular biology. Identification of ALK pathway activation could allow for more targeted treatment. SAN FRANCISCO...
Filed under: Press Releases, Research, Treatment, Breast Cancer, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, meeting, National Cancer Institute, NCI, Molecular Targets, AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, Cancer Therapeutics, EORTC, metastasis, European Organisation for Research and Treatment of Cancer, Dr. Fredika M. Robertson, inflammatory breast cancer, anaplastic lymphoma kinase, ALK, Dr. Massimo Cristofanilli